Keywords: aveo, licenses, peptech, superhumanisation, technology, australian, drugmaker

AVEO licenses Peptech's Superhumanisation technology

Article | 08 October 2007

Australian drugmaker Peptech and the USA's AVEO Pharmaceuticals have entered into a non-exclusive research and commercialization agreement in which the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in